Do Antioxidants and Vitamin C Blunt HBOT? The Redox-Signaling Question

There's a worry that quietly spreads through hyperbaric forums and wellness clinics: if hyperbaric oxygen therapy (HBOT) works by creating a brief burst of reactive oxygen species, then swallowing a fistful of vitamin C and other antioxidants might cancel the whole thing out. The logic sounds airtight, and it borrows from real science in exercise physiology. But when you actually trace the claim back to human HBOT studies, the evidence gets thin, mixed, and a lot more interesting than the simple "antioxidants block HBOT" headline suggests.

This article walks through the redox-signaling mechanism that gives the worry its teeth, separates what's proven from what's extrapolated, and lays out a sober timing protocol you can discuss with your physician.

The Core Idea: HBOT Is Partly an Oxidative Stress Therapy

For decades, people assumed HBOT just floods tissue with oxygen so cells have more fuel. That's part of it. But the more surprising finding is that HBOT also works by deliberately stressing cells with a controlled, short pulse of reactive oxygen species (ROS) and reactive nitrogen species (RNS).

When you breathe 100% oxygen at 2 to 2.4 times atmospheric pressure, dissolved oxygen in your plasma climbs roughly 10- to 15-fold. That hyperoxia generates more superoxide, hydrogen peroxide, and related molecules than your cells normally see. Instead of being purely toxic, those molecules act as signals. They flip on genetic switches that the cell reads as "time to repair and adapt."

The foundational argument here comes from Stephen Thom's review, titled, bluntly, "Oxidative stress is fundamental to hyperbaric oxygen therapy". Thom laid out how the ROS and RNS burst from HBOT drives several therapeutic effects:

• Growth factor production — VEGF, basic fibroblast growth factor, and TGF-beta1, which build new blood vessels in wounds.
• Stem cell mobilization — HBOT stimulates nitric oxide synthase (NOS-3) in bone marrow, which releases vasculogenic stem/progenitor cells into circulation.
• HIF stabilization — oxidative stress paradoxically stabilizes hypoxia-inducible factors (HIF-1alpha and HIF-2alpha), which switch on tissue-repair genes.
• Antioxidant enzyme upregulation — the cell responds to the stress by building up its own defenses, including heme oxygenase-1 (HO-1), superoxide dismutase (SOD), and thioredoxin, largely through the Nrf2 pathway.

That last point is the key to the whole debate. HBOT doesn't just create oxidative stress — it triggers a wave of the body's own antioxidant machinery in response. This is a textbook case of hormesis: a low dose of a stressor that produces a net-beneficial adaptation. The cell ends up better defended than before.

It helps to picture the timeline. During a 90-minute session, the oxygen pressure pushes ROS up. Sensors inside the cell — chiefly a protein called Keap1 that normally keeps Nrf2 in check — get oxidized and let Nrf2 go. Nrf2 travels to the nucleus and switches on a battery of protective genes: SOD, catalase, glutathione-making enzymes, HO-1. By the time you climb out of the chamber, the ROS spike is fading but the protective response is ramping up and stays elevated for hours. Repeat this over a course of 20 to 40 sessions and the tissue is steadily nudged toward a more repair-ready, better-defended state. The "stress" is the messenger; the lasting change is the adaptation it triggers.

That distinction — messenger versus damage — is the whole reason the antioxidant question is subtle. An antioxidant taken at the wrong moment doesn't just blunt "damage." It can mute the messenger.

Why This Makes People Nervous About Vitamin C

Here's the inference that drives the worry. If the brief ROS pulse is the signal that tells cells to heal, and antioxidant supplements like vitamin C exist specifically to quench ROS, then taking high-dose antioxidants around your HBOT sessions might mop up the signal before it's heard. No signal, no adaptation, no benefit. You'd be paying for sessions and then chemically deleting their effect.

It's a clean, intuitive argument. The problem is that intuition and proof are not the same thing.

Where the Worry Actually Comes From: Exercise Science

The strongest direct evidence that antioxidants can blunt a hormetic, ROS-driven adaptation doesn't come from HBOT at all. It comes from exercise physiology, and it's genuinely solid in that setting.

Exercise, like HBOT, produces a ROS burst that signals cells to adapt — in this case, building more mitochondria and improving endurance. Several well-designed human trials found that high-dose antioxidant supplements interfered with those gains:

So the principle is real: in exercise, high-dose vitamin C and E really can dampen a ROS-mediated adaptive response. This is well-replicated.

Notice the doses in that table, too. These were grams of vitamin C — 1 full gram per day, often paired with several hundred IU of vitamin E. That's roughly 10 times the recommended daily intake of vitamin C. Nobody in these trials was taking a normal multivitamin and watching their gains vanish. It took deliberate mega-dosing to move the needle, which fits the hormetic dose-response: small amounts do little, large amounts inhibit. Hold onto that number, because it matters a lot when people start worrying about a 90 mg vitamin C tablet sabotaging their HBOT.

But two cautions matter before you map this onto HBOT. First, even in exercise the picture is "mixed, leaning negative," not unanimous — some trials found no effect on long-term performance, and the effect appears dose-dependent (the hormetic curve: small doses neutral or helpful, large doses inhibitory). Second, and more important: exercise and HBOT are not the same stimulus. The ROS source, magnitude, tissue, and timing all differ. Borrowing a conclusion from one and stamping it onto the other is an assumption, not a finding.

What the Actual HBOT Evidence Shows

This is where honest grading matters. When you search specifically for studies on antioxidants plus HBOT in humans, the cupboard is surprisingly bare, and what's there doesn't cleanly support the "vitamin C blunts HBOT" claim.

The one direct human study used vitamin C and found... it didn't even reduce HBOT's oxidative stress

The most relevant trial is from the British Journal of Nutrition: "Effect of hyperbaric oxygen and vitamin C and E supplementation on biomarkers of oxidative stress in healthy men". Nineteen healthy men were exposed to HBO (100% oxygen at 240 kPa, roughly 2.4 ATA) before and after 4 weeks of taking 500 mg vitamin C plus 165 mg alpha-tocopherol equivalents daily.

The result was the opposite of what the "blunting" theory predicts. HBO still caused clear oxidative stress — plasma lipid peroxides rose, urinary 8-oxo-deoxyguanosine (a DNA damage marker) rose — and the vitamin C plus E supplementation did not prevent it. The authors concluded the oxidative stress from HBO "could not be prevented by dietary vitamin C plus E supplementation."

Read that carefully. If a moderate dose of vitamin C and E can't even blunt HBO's oxidative stress markers in healthy people, the simple story that vitamin C "cancels out" HBOT's ROS signal loses a lot of its force. The supplement wasn't strong enough to win the tug-of-war against the oxygen.

The catch: this study measured oxidative stress markers, not clinical healing outcomes. It tells us the supplement didn't suppress the ROS signal much. It does not prove the combination is safe or beneficial for therapy outcomes, because nobody followed wound healing, cognition, or any endpoint that patients actually care about.

The animal and mechanistic data center on NAC, not vitamin C

Most of the "antioxidants blunt HBOT" mechanistic evidence involves N-acetylcysteine (NAC), a far more potent antioxidant than dietary vitamin C, and it comes from animal models. A 2026 review in Frontiers in Medicine, "Hyperbaric oxygen therapy and N-acetylcysteine: a redox-dependent interaction", is the best synthesis available. Its conclusions are nuanced, and they cut against any one-size-fits-all rule:

The review's own bottom line: the interaction "is neither universally synergistic nor antagonistic." Whether an antioxidant hurts or helps depends on baseline oxidative status, dose, and timing.

There's a clinical thread worth pulling here, because it flips the worry on its head. In Efrati's human work on diabetic foot ulcers — "Hyperbaric oxygen, oxidative stress, NO bioavailability and ulcer oxygenation in diabetic patients" — about a third of patients (17 of 50) were "non-responders." Their tissue oxygen didn't rise the way it should during HBOT, and their measured oxidative stress went the wrong direction: antioxidant status and nitric oxide fell while a damage marker rose. For those patients, who were drowning in pathological oxidative stress, adding the antioxidant NAC actually helped — it restored nitric oxide availability and improved tissue oxygenation. Patients who were already responding well to HBOT got no extra benefit from NAC.

So the same antioxidant was useless-or-harmful in healthy signaling and helpful in a high-pathology, stuck-wound setting. That's the opposite of a simple "antioxidants bad" rule. Context is doing all the work.

And critically — NAC is not vitamin C. NAC is a strong, glutathione-boosting thiol antioxidant often dosed at 600 to 1,800 mg of a much more reactive compound. Extrapolating from animal NAC studies to a human taking a 500 mg vitamin C tablet is a stretch the evidence doesn't license.

Evidence grade, stated plainly

The honest summary: the mechanism for concern is real, the exercise analogy is real, but the direct human proof that ordinary vitamin C blunts HBOT is missing. This is a theoretical caution, not a demonstrated effect.

The Other Half of the Story: Vitamin C Helps Wounds Heal

Any timing protocol has to account for an inconvenient fact that the "stop all antioxidants" crowd glosses over: vitamin C is required for the exact healing HBOT is trying to achieve.

Vitamin C is an essential cofactor for the enzymes that build collagen. Without it, wounds don't close properly — that's literally what scurvy is. Deficiency is common in the chronic-wound and diabetic populations who make up most HBOT patients, and nutritional surveys of HBOT referrals find a meaningful share arrive malnourished or low in micronutrients.

So the framing "vitamin C is the enemy of HBOT" collapses on contact with wound-care reality. A vitamin-C-deficient patient with a non-healing ulcer almost certainly heals worse, not better, if you withhold vitamin C to "protect the ROS signal." The redox-signaling worry is about excess, high-dose, timed antioxidants suppressing a transient signal — not about the baseline vitamin C your collagen needs.

This is the real tension a good protocol resolves: keep enough vitamin C for substrate-level healing, without piling on mega-doses that might dampen the redox pulse.

A Sober Supplement-Timing Protocol

There's no randomized trial telling you the optimal schedule. What follows is a reasonable, conservative framework built from the mechanism and the timing signal in the NAC data — not a medical prescription. Run it past the physician supervising your HBOT.

1. Don't go without basic vitamin C

Maintain normal dietary or modest supplemental vitamin C (roughly the RDA, about 75 to 90 mg/day, up to a few hundred mg if your clinician is correcting a deficiency). This supports collagen synthesis. There is no good reason to make yourself deficient.

2. Avoid mega-doses in the hours around a session

If the redox-signaling worry has any teeth, the vulnerable window is right around the ROS pulse. The animal NAC data consistently show that antioxidant before or during HBOT is what blunts signaling. So if you take high-dose antioxidants (grams of vitamin C, high-dose vitamin E, NAC, alpha-lipoic acid, high-dose CoQ10, glutathione), the cautious move is to not take them in the few hours before or right after a dive.

3. If you want high-dose antioxidants, separate them from sessions

A common practical approach is to take any large antioxidant doses on the opposite side of the day from your HBOT session, or on non-treatment days. This preserves the acute redox signal while still letting you supplement. Again — plausible, not proven.

4. Never stop a prescribed NAC or antioxidant regimen on your own

Some patients are on NAC or other antioxidants for a real medical reason (acetaminophen toxicity, certain pulmonary or liver conditions, specific protocols). And remember the Frontiers review: in high-pathology states, the combination can be synergistic. Don't self-discontinue a prescribed drug based on a wellness-forum theory. That's a conversation for your prescriber.

5. Skip the "antioxidant IV before HBOT" upsell

Some clinics sell high-dose IV vitamin C or glutathione drips bundled with HBOT. This is precisely the scenario — potent antioxidant, intravenous, timed right around the session — where the theoretical blunting risk is highest and the benefit is least proven. There's no outcome data supporting the combo, and a mechanistic reason to be skeptical.

Safety Notes

• CNS oxygen toxicity and antioxidants: A long-standing idea is that vitamin E might protect against the rare oxygen-toxicity seizures seen in hyperbaric/diving settings. The evidence is disappointing. StatPearls and the broader literature note that vitamin E deficiency raises seizure risk, but supplemental vitamin E has failed to prevent HBO seizures in studies. Don't rely on any supplement as seizure protection.
• High-dose vitamin C isn't free of risk: Grams of vitamin C can cause GI upset and, in people with kidney stones or certain conditions, raise oxalate load. More is not automatically better.
• Drug interactions: Antioxidants can interact with chemotherapy, radiation, and certain medications. If you're doing HBOT alongside cancer treatment, the antioxidant-timing question is its own complex topic — handle it with your oncology team.

Who This Matters For

• Wellness / longevity HBOT users stacking heavy supplement regimens: this is the group most likely to be over-supplementing antioxidants right around sessions. The cautious timing rules above are most relevant to you.
• Chronic wound and diabetic foot ulcer patients: your bigger risk is deficiency, not excess. Keep adequate vitamin C; don't withhold it.
• Athletes using HBOT for recovery: you already live in the exercise-antioxidant literature. The same hormesis logic that says "don't mega-dose vitamin C right after a hard session to protect mitochondrial adaptation" reasonably extends to HBOT.
• Patients on prescribed NAC or antioxidant protocols: don't change anything without your prescriber. Your case may even be one where the combination helps.

The Bottom Line

The mechanism is real: HBOT works partly through a transient redox signal, and in principle a strong, well-timed antioxidant could mute it. The exercise literature proves this kind of blunting can happen with high-dose vitamin C and E. But the leap from "exercise" and "animal NAC studies" to "your vitamin C tablet is wrecking your HBOT" is not supported by direct human outcome data — and the one human study that combined vitamin C with HBO found the vitamin couldn't even suppress the oxidative markers. Meanwhile, vitamin C is genuinely needed for the healing HBOT promotes.

The reasonable response isn't fear or dogma. It's timing. Keep your baseline vitamin C, avoid mega-doses in the hours around a session, separate any high-dose antioxidants from your dives, and let your physician steer anything prescribed.

Frequently Asked Questions

Does taking vitamin C ruin my hyperbaric oxygen therapy?

There's no human evidence that ordinary vitamin C ruins HBOT outcomes. The concern is theoretical, borrowed from exercise studies where high-dose vitamin C blunted adaptation. The one study that combined vitamin C with hyperbaric oxygen in people found the vitamin didn't even reduce the oxygen-driven oxidative stress, let alone cancel the therapy. Keep normal vitamin C; just avoid mega-doses right around sessions.

How long before or after HBOT should I avoid antioxidants?

No trial has pinned down an exact window. The cautious, mechanism-based approach is to avoid high-dose antioxidants (grams of vitamin C, high-dose vitamin E, NAC, glutathione) in roughly the few hours before and after a session, since animal data show antioxidants given before or during HBOT are the ones that blunt signaling. Many people simply take large doses on the opposite side of the day or on non-treatment days.

Is NAC the same risk as vitamin C with HBOT?

No. NAC is a much stronger antioxidant and is the compound behind most of the "blunting" animal studies. Even so, the 2026 Frontiers review found NAC plus HBOT can be either harmful or helpful depending on timing, dose, and how much pathological oxidative stress is present. Never stop a prescribed NAC regimen on your own — in some conditions the combination actually helps.

Should diabetic foot ulcer patients stop vitamin C during HBOT?

Almost certainly not. Vitamin C is essential for collagen and wound healing, and deficiency is common in this group. Withholding it to "protect the redox signal" risks worse healing, which is the opposite of the goal. The redox worry is about timed mega-doses, not the baseline vitamin C your tissue needs to repair.

Are clinic IV vitamin C or glutathione drips bundled with HBOT a good idea?

This is the scenario with the weakest evidence and the highest theoretical risk: a potent antioxidant, delivered intravenously, timed right around the oxygen pulse. No outcome data support the combination, and there's a mechanistic reason to expect it could blunt the signal HBOT depends on. Treat these bundled upsells with skepticism and ask the clinic for evidence.

This article is for educational purposes only and is not medical advice. Talk to a qualified physician before starting, stopping, or timing any supplement around hyperbaric oxygen therapy, especially if you have a chronic wound, are receiving cancer treatment, or take prescribed antioxidants.

Related Reading

• How Hyperbaric Oxygen Therapy Works: The Complete 2026 Science Guide
• HBOT and Nutrition: Pre-Session Guidelines
• HBOT and Medication Interactions to Know
• HBOT for Diabetic Foot Ulcers: Clinical Trial Evidence
• Oxygen Toxicity in HBOT: Real Risks Explained